EGM

iClick Interactive Asia Group Limited Announces Shareholders' Approval of Merger Agreement

Retrieved on: 
Friday, March 8, 2024

Each shareholder has one vote for each Class A Share or 20 votes for each Class B Share.

Key Points: 
  • Each shareholder has one vote for each Class A Share or 20 votes for each Class B Share.
  • The Merger Agreement, the Plan of Merger and the transactions contemplated thereby, including the Merger, were approved by approximately 99.77% of the total votes cast at the EGM.
  • The completion of the Merger is subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement.
  • The Company will work with the other parties to the Merger Agreement towards satisfying all other conditions precedent to the Merger set forth in the Merger Agreement and completing the Merger as quickly as possible.

Nabsys Opens a Distribution Channel for the OhmX™ Platform in Canada

Retrieved on: 
Thursday, March 7, 2024

PROVIDENCE, R.I., March 7, 2024 /PRNewswire/ -- Next generation genomic tools company, Nabsys®, has executed a nonexclusive agreement with Canadian distributor, DMark Biosciences ("DMark"), for sales of its OhmX™ platform.

Key Points: 
  • PROVIDENCE, R.I., March 7, 2024 /PRNewswire/ -- Next generation genomic tools company, Nabsys®, has executed a nonexclusive agreement with Canadian distributor, DMark Biosciences ("DMark"), for sales of its OhmX™ platform.
  • OhmX is Nabsys' first commercially available product and was released in October 2023.
  • DMark will be responsible for distributing both the Nabsys OhmX™ Analyzer and consumables into both public and private research core labs and institutions in the Canadian market.
  • "With growing demand for the OhmX platform in the US, this distribution agreement marks an important step towards establishing a strong global distribution network," Nabsys' Chief Commercial Officer, Justin Bingham, remarked.

YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting

Retrieved on: 
Saturday, February 17, 2024

The following persons be elected as Directors with immediate effect: (i) Ms Nan Zhang; (ii) Ms Yun (Monica) Zhang; (iii) Mr Lui Chi Keung (Peter); (iv) Mr Jing Xian Li.

Key Points: 
  • The following persons be elected as Directors with immediate effect: (i) Ms Nan Zhang; (ii) Ms Yun (Monica) Zhang; (iii) Mr Lui Chi Keung (Peter); (iv) Mr Jing Xian Li.
  • As of the close of business on the EGM's record date of February 8, 2024, the Company had 188,327,959 ordinary shares issued and outstanding.
  • The results of the vote on each of the resolutions submitted for shareholder approval at the EGM were zero vote in favor and 97,272,542 votes against.
  • Further, Article 88 of the Articles permits a director to attend and be heard on any motion for his removal.

Shareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd.

Retrieved on: 
Friday, February 16, 2024

Yi Zhang thanks his fellow shareholders for their support in achieving this positive outcome today.

Key Points: 
  • Yi Zhang thanks his fellow shareholders for their support in achieving this positive outcome today.
  • The actions taken reflect an overwhelming shareholder repudiation of the prior board of directors  of the Company (the "Board") and the total disregard for shareholder perspectives shown by the prior Board and management team.
  • Given the result of the vote, Yi Zhang is confident that YS will now be able to focus its full efforts on executing its business strategy and preserving and growing long-term value for all shareholders.
  • These statements involve risks, uncertainties and other factors that may cause actual results, events or achievements to differ materially from the information expressed or implied by these statements.

Result of EGM

Retrieved on: 
Friday, February 16, 2024

* A vote withheld is not a vote in law and is not counted in the proportion of votes for or against a resolution.

Key Points: 
  • * A vote withheld is not a vote in law and is not counted in the proportion of votes for or against a resolution.
  • This Board recognises this result reflects well publicised differences of opinion apparent in certain sections of the register and notes the public statements made by CAPREIT and Ewing Morris ahead of this EGM.
  • The Board takes seriously its responsibility to understand shareholders’ opinions and to minimise conflict and will continue to engage with all shareholders constructively and to act in all shareholders interests.
  • For further information please contact:
    For Investor Relations at Irish Residential Properties REIT plc:
    Padraig McKeon, I-RES PR and Communications Tel: + 353 (0) 87 231 2632

Bulletin from Kindred Group plc's Extraordinary General Meeting

Retrieved on: 
Friday, February 16, 2024

VALLETTA, Malta, Feb. 16, 2024 /PRNewswire/ -- At Kindred Group plc's ("Kindred" or the "Company") extraordinary general meeting held on 16 February 2024 (the "EGM") 42.16 percent in nominal value of the total shares/Swedish depository receipts ("SDRs") in issue were represented at the meeting and 99.97 percent of the shares/SDRs represented (42.14 percent of the total shares/SDRs in issue) voted in favor of the Board of Directors' proposal to amend the Company's current Memorandum and Articles of Association to, inter alia, include squeeze-out rights for an offeror.

Key Points: 
  • VALLETTA, Malta, Feb. 16, 2024 /PRNewswire/ -- At Kindred Group plc's ("Kindred" or the "Company") extraordinary general meeting held on 16 February 2024 (the "EGM") 42.16 percent in nominal value of the total shares/Swedish depository receipts ("SDRs") in issue were represented at the meeting and 99.97 percent of the shares/SDRs represented (42.14 percent of the total shares/SDRs in issue) voted in favor of the Board of Directors' proposal to amend the Company's current Memorandum and Articles of Association to, inter alia, include squeeze-out rights for an offeror.
  • In accordance with Article 135 of the Companies Act (Cap.
  • As these requirements were not met, the Board of Directors is to convene a second extraordinary general meeting (the "Second EGM") within 30 days to take a fresh vote on the proposal to amend the Company's current Memorandum and Articles of Association in accordance with the rules set out in Article 135(1)(b) of the Companies Act (Cap.
  • 386 of the Laws of Malta).

Bulletin from Kindred Group plc's Extraordinary General Meeting

Retrieved on: 
Friday, February 16, 2024

VALLETTA, Malta, Feb. 16, 2024 /PRNewswire/ -- At Kindred Group plc's ("Kindred" or the "Company") extraordinary general meeting held on 16 February 2024 (the "EGM") 42.16 percent in nominal value of the total shares/Swedish depository receipts ("SDRs") in issue were represented at the meeting and 99.97 percent of the shares/SDRs represented (42.14 percent of the total shares/SDRs in issue) voted in favor of the Board of Directors' proposal to amend the Company's current Memorandum and Articles of Association to, inter alia, include squeeze-out rights for an offeror.

Key Points: 
  • VALLETTA, Malta, Feb. 16, 2024 /PRNewswire/ -- At Kindred Group plc's ("Kindred" or the "Company") extraordinary general meeting held on 16 February 2024 (the "EGM") 42.16 percent in nominal value of the total shares/Swedish depository receipts ("SDRs") in issue were represented at the meeting and 99.97 percent of the shares/SDRs represented (42.14 percent of the total shares/SDRs in issue) voted in favor of the Board of Directors' proposal to amend the Company's current Memorandum and Articles of Association to, inter alia, include squeeze-out rights for an offeror.
  • In accordance with Article 135 of the Companies Act (Cap.
  • As these requirements were not met, the Board of Directors is to convene a second extraordinary general meeting (the "Second EGM") within 30 days to take a fresh vote on the proposal to amend the Company's current Memorandum and Articles of Association in accordance with the rules set out in Article 135(1)(b) of the Companies Act (Cap.
  • 386 of the Laws of Malta).

Important Alert on EGM Votes Submitted Via Broadridge

Retrieved on: 
Friday, February 9, 2024

Irish Residential Properties REIT plc (“I-RES”) issues this important alert for all I-RES shareholders who have submitted voting instructions for the Extraordinary General Meeting (“EGM”) convened for 16 February 2024 via third-party service provider, Broadridge Financial Solutions Limited (“Broadridge”).

Key Points: 
  • Irish Residential Properties REIT plc (“I-RES”) issues this important alert for all I-RES shareholders who have submitted voting instructions for the Extraordinary General Meeting (“EGM”) convened for 16 February 2024 via third-party service provider, Broadridge Financial Solutions Limited (“Broadridge”).
  • Following an error on the Broadridge voting instruction platform, all voting instructions for the EGM submitted via the Broadridge voting platform have been cancelled.
  • Shareholders are requested to resubmit their voting instructions through the Broadridge voting platform when they receive the alert from Broadridge in order that their votes be counted at the EGM.
  • I-RES urges its shareholders to resubmit their voting instructions through the Broadridge voting platform as soon as you receive the alert from Broadridge.

Shareholders of YS Biopharma Announce an Extraordinary General Meeting

Retrieved on: 
Thursday, February 8, 2024

US Pacific Standard Time, and for any adjourned or postponed meeting thereof, for the purposes set forth in the accompanying Notice of EGM.

Key Points: 
  • US Pacific Standard Time, and for any adjourned or postponed meeting thereof, for the purposes set forth in the accompanying Notice of EGM.
  • Any shareholder appointing such a proxy has the power to revoke it at any time before it is voted.
  • Alternatively, revocation of proxy may be effected by the shareholder attending and voting in person at the EGM.
  • However, we encourage shareholders to vote by proxy, when possible, in order to simplify vote tabulation during the EGM.

Ascendent Wins Overwhelming Shareholder Support to Acquire Hollysys for US$26.50 Per Share

Retrieved on: 
Thursday, February 8, 2024

Ascendent is committed to securing regulatory approvals and closing the acquisition expeditiously.

Key Points: 
  • Ascendent is committed to securing regulatory approvals and closing the acquisition expeditiously.
  • The EGM concluded with the overwhelming majority of Hollysys shareholders approving all resolutions, including the resolution pursuant to which Ascendent will acquire all outstanding shares of Hollysys that it does not currently own for US$26.50 per share in cash.
  • Leon Meng, Chairman and CEO of Ascendent, commented: "Today marks an important milestone for Hollysys, its investors, management, and staff.
  • We also want to thank Hollysys shareholders for their strong support and will work towards securing the required regulatory approvals expeditiously.